Literature DB >> 18485478

FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.

Jee Hoon Song1, Nikolai Schnittke, April Zaat, Christine S Walsh, Carl W Miller.   

Abstract

The FBXW7 (also known as AGO, hCDC4, FBW7 and SEL-10) gene encodes a subunit of an ubiquitin protein ligase which regulates levels of cyclin E, NOTCH and other proteins. Engineered FBXW7 null cells display cell cycle and chromosome stability defects. Mutations of FBXW7 have been found in human colorectal, ovarian, endometrial tumors and T-cell acute lymphocytic leukemias. Prompted by these findings we have examined acute myeloid leukemia, non-Hodgkin's lymphoma, T-cell acute lymphocytic leukemia, B-cell acute lymphocytic leukemia and adult T-cell leukemia DNA for mutations of the FBXW7 gene. Mutations were detected by PCR-SSCP of all coding exons of the three isoforms of FBXW7, shifted bands were direct sequenced. As expected, mutations were found in T-cell acute lymphocytic leukemias. However mutations of FBXW7 were also found in four of 118 B-cell acute lymphocytic leukemias and one of 24 adult T-cell leukemia samples. The nucleotide changes consisted of an insertion, resulting in a frameshift mutation, and missense mutations of highly conserved residues. All mutations affected the FBXW7 target interacting domain. These observations suggest that disruption of FBXW7 has a role in several forms of lymphocytic leukemias and not exclusively T-cell acute lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485478     DOI: 10.1016/j.leukres.2008.03.040

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

Review 1.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

2.  The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

Authors:  Eric K Lee; Zhaorui Lian; Kurt D'Andrea; Richard Letrero; WeiQi Sheng; Shujing Liu; J Nathaniel Diehl; Dariusz Pytel; Olena Barbash; Lynn Schuchter; Ravi Amaravaradi; Xiaowei Xu; Meenhard Herlyn; Katherine L Nathanson; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

3.  Molecular pathways: turning proteasomal protein degradation into a unique treatment approach.

Authors:  Sebastian Stintzing; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2014-04-22       Impact factor: 12.531

4.  FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.

Authors:  Yan Song; Xinjia Zhou; Weiliang Bai; Xiulan Ma
Journal:  Tumour Biol       Date:  2015-01-14

5.  E3 Ubiquitin Ligase Fbw7 Regulates the Survival of Mature B Cells.

Authors:  Parham Ramezani-Rad; Charlotte R Leung; John R Apgar; Robert C Rickert
Journal:  J Immunol       Date:  2020-01-31       Impact factor: 5.422

6.  Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.

Authors:  Ichiro Onoyama; Atsushi Suzuki; Akinobu Matsumoto; Kengo Tomita; Hideki Katagiri; Yuichi Oike; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

Review 7.  Tumor suppressor functions of FBW7 in cancer development and progression.

Authors:  Zhiwei Wang; Hiroyuki Inuzuka; Jiateng Zhong; Lixin Wan; Hidefumi Fukushima; Fazlul H Sarkar; Wenyi Wei
Journal:  FEBS Lett       Date:  2012-03-21       Impact factor: 4.124

8.  Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.

Authors:  Marc R Mansour; Maria L Sulis; Veronique Duke; Letizia Foroni; Sarah Jenkinson; Kenneth Koo; Christopher G Allen; Rosemary E Gale; Georgina Buck; Sue Richards; Elisabeth Paietta; Jacob M Rowe; Martin S Tallman; Anthony H Goldstone; Adolfo A Ferrando; David C Linch
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

9.  Notch1 is an effector of Akt and hypoxia in melanoma development.

Authors:  Barbara Bedogni; James A Warneke; Brian J Nickoloff; Amato J Giaccia; Marianne Broome Powell
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

10.  Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia.

Authors:  Emanuela M Ghia; Laura Z Rassenti; Donna S Neuberg; Alejandro Blanco; Fouad Yousif; Erin N Smith; John D McPherson; Thomas J Hudson; Olivier Harismendy; Kelly A Frazer; Thomas J Kipps
Journal:  Blood       Date:  2019-03-28       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.